The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
出版年份 2019 全文链接
标题
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 10, Pages 2539
出版商
MDPI AG
发表日期
2019-05-24
DOI
10.3390/ijms20102539
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
- (2016) Henrik H. Hansen et al. BRAIN RESEARCH
- Type 2 Diabetes Mellitus and Alzheimer's Disease: Bridging the Pathophysiology and Management
- (2016) Fahmida Alam et al. CURRENT PHARMACEUTICAL DESIGN
- Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes
- (2016) Trevor Hardigan et al. LIFE SCIENCES
- Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease
- (2016) Jayasankar Kosaraju et al. MOLECULAR NEUROBIOLOGY
- DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice
- (2015) MingJie Ma et al. Cardiovascular Diabetology
- Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline
- (2015) V. A. Gault et al. DIABETES OBESITY & METABOLISM
- A Novel Mouse Model of Subcortical Infarcts with Dementia
- (2015) Y. Hattori et al. JOURNAL OF NEUROSCIENCE
- Cognitive function in patients with diabetes mellitus: guidance for daily care
- (2015) Paula S Koekkoek et al. LANCET NEUROLOGY
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- Aberrant insulin signaling in Alzheimer's disease: current knowledge
- (2015) Gaurav Bedse et al. Frontiers in Neuroscience
- The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease
- (2014) Konrad Talbot et al. Alzheimers & Dementia
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- Insulin dysfunction and Tau pathology
- (2014) Noura B. El Khoury et al. Frontiers in Cellular Neuroscience
- Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
- (2014) Inês Sebastião et al. Frontiers in Endocrinology
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
- (2012) Swenja Kröller-Schön et al. CARDIOVASCULAR RESEARCH
- Lipid Sensing and Insulin Resistance in the Brain
- (2012) Jessica T.Y. Yue et al. Cell Metabolism
- Detrimental Effects of Diet-Induced Obesity on Pathology Are Independent of Insulin Resistance in Transgenic Mice
- (2012) A. Leboucher et al. DIABETES
- Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures
- (2012) Dong-Hou Kim et al. NEUROBIOLOGY OF DISEASE
- The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease
- (2012) Caitriona M. Long-Smith et al. NEUROMOLECULAR MEDICINE
- Insulin resistance and Alzheimer's disease
- (2011) Suzanne M. De La Monte BMB Reports
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
- (2011) Amit Gupta et al. NEUROPHARMACOLOGY
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection
- (2010) Alexander Harkavyi et al. BRITISH JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started